Opaleye Management Inc. Infinity Pharmaceuticals, Inc. Transaction History

Opaleye Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 18, 2021	SELL	$1.98 - $5.36 $6.28 Million - $17 Million	-3,171,800 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.82 - $1.34 $2.6 Million - $4.25 Million	3,171,800 New	3,171,800 $137,000
Q4 2018 Feb 14, 2019	SELL	$1.01 - $2.78 $277,750 - $764,500	-275,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.72 - $2.71 $473,000 - $745,250	275,000 New	275,000 $745,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.